Polycystic Ovarian Syndrome: A Breakthrough Etiology, Symptoms and Therapy

Polycystic ovarian disease or syndrome (PCOD or PCOS), a metabolic disturbance that is common in women of fertility age, is characterized by increased levels of androgens and ovulatory dysfunction. The primary cause of PCOD is insulin resistance, although genetic and environmental factors also play a role. Insulin receptors, which are mostly found in adipose tissue, the liver, and skeletal muscle, trigger intracellular signaling pathways such as PI3K, AKT, and MAPK-ERK when they bind. These mechanisms regulate the absorption, storage, and metabolism of lipids. Numerous potential genes related to steroid synthesis and the insulin cascade have been found by genome-wide association studies (GWASs). GWASs have recognized some potential genes involved with steroid synthesis and insulin signaling. The management of PCOD requires many strategies, including changing lifestyle, increasing exercise, weight loss, surgical intervention, and utilizing pharmaceuticals to enhance sensitivity to insulin and ovulation, such as antiandrogens, metformin, thiazolidinediones, aromatase inhibitors, and ovulation enhancers, as well as combined oral contraceptives with or without cyproterone to restore a regular menstrual Cycle.